Latest News about EDIT
Recent news which mentions EDIT
Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia
April 26, 2022
Tickers
EDIT
From Benzinga
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
From Motley Fool
From Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
From Motley Fool
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
From Benzinga
From Benzinga
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
51 Biggest Movers From Yesterday
February 09, 2022
From Benzinga
Editas Suddenly Terminates Chief Medical Officer Without An Explanation
February 08, 2022
Tickers
EDIT
From Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
February 08, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 08, 2022
From Benzinga
From InvestorPlace
21 Stocks Moving in Tuesday's Pre-Market Session
February 08, 2022
From Benzinga
2 Biotech Stocks That Could Skyrocket This Year
February 02, 2022
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Why Editas Medicine Stock Is Tumbling This Week
January 13, 2022
From Motley Fool
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
Top 5 Moonshots for 2022 Countdown: My No. 5 Pick
December 22, 2021
From InvestorPlace
NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
December 13, 2021
From InvestorPlace
From InvestorPlace
EDIT Stock: The Preclinical Data Sending Editas Medicine Rallying Today
December 13, 2021
From InvestorPlace
22 Stocks Moving in Monday's Pre-Market Session
December 13, 2021
From Benzinga
Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?
December 08, 2021
From Motley Fool
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.